Deals
Health-Tech Firm Olive Valued at $4 Billion After New Round
This article is for subscribers only.
Olive, a digital-health startup looking to use technology to help health-care firms automate tasks, has closed a funding round that values it at $4 billion, about seven months after it was worth $1.5 billion.
The $400 million round was led by private equity firm Vista Equity Partners and Base10 Partners’ Advancement Initiative, according to a statement Thursday that confirmed an earlier Bloomberg News report. Existing investor Tiger Global Management also joined the round.